세계의 3D 세포배양 시장 규모, 점유율 및 성장 분석 : 제품별, 용도별, 최종사용자별, 유형별 - 산업 예측(2023년-2030년)
Global 3D Cell Culture Market Size, Share, Growth Analysis, By Products, By Application, By End User, By By Type - Industry Forecast 2023-2030
세계 3D 세포배양 시장 규모는 2022년 13억 달러에서 2030년까지 47억 7,000만 달러에 달할 것으로 예상되며, 예측 기간(2023-2030년) 동안 15.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.
이 보고서는 세계의 3D 세포배양(3D Cell Culture) 시장을 조사 분석하여 시장 역학 및 전망, 부문 분석, 기업 프로파일 등의 정보를 제공합니다.
3D Cell Culture Market size was valued at USD 1.12 billion in 2021 and is poised to grow from USD 1.3 billion in 2022 to USD 4.77 billion by 2030, growing at a CAGR of 15.6% in the forecast period (2023-2030).
With the introduction of new technologies like 3D cell culture, the life sciences sector is undergoing a rapid transformation. Tissue engineering, drug discovery, stem cell research, and many other fields have changed as a result of the introduction of this promising technique. A shift in trends towards changed research approaches and the use of cell culture in vivo-like models to understand cell behaviour has been brought about by the rapid adoption of 3D cell culture technologies in both academic and industrial sectors. This is fueling the growing need for superior 3D cell culture solutions in the market.
3D cultures are commonly employed in studies that require in vivo model systems to evaluate how a foreign substance affects body tissues and organs because they can faithfully mimic the normal morphology and microarchitecture of organs. The use of bio-mimetic tissue constructs to create 3D organotypic structures also led to the widespread use of 3-dimensional cell culture techniques by research organisations. A fresh strategy for treating COVID-19, cancer, and other clinical disorders has also been developed: employing 3D tissue-engineered models. When compared to 2D methods, this also shows a lot of potential in terms of providing an easy-to-use and economical in vitro tumor-host environment.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global 3D Cell Culture Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The Global 3D Cell Culture Market is segmented based on Product, Application, End-User, and Region. Based on Product it is categorized into Scaffold-Based 3D cell culture, Scaffold-Free 3D cell culture, Microfluidics, and 3D Bioreactors. Based on Application it is categorized into Cancer Treatment, Stem Cell Research, Drug Discovery, and Regenerative Medicine. Based on End-user it is categorized into Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes. Based on type, the market is segmented into hydrogel, ECM, hanging drop, bioreactor, microfluidics, and magnetic levitation. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
The United States has recently made large investments in the subject of bioengineering, which also includes research into 3D cell culture. According to a 2020 report by the National Institute of Health, USD 5,646 was invested overall in bioengineering technologies, up from USD 5,091 in 2019. The market for 3D cell culture in the US has grown due to these considerations.
As the need for organ transplants increases globally, there is an anticipated increase in demand for 3D cell cultures. A total of 3,014 transplant surgeries were carried out in Canada, according to a 2021 study by the Canadian Institute for Health. which represents an increase of 42% from 2010. The growth of the 3D Cell Culture Market in the region is therefore anticipated to be accelerated by all of the aforementioned factors throughout the projected timeframe.
The main thing stopping the global 3D cell culture industry from expanding is The lack of uniformity in 3D cell culture products makes up the market for such items in 3D. When inserting scaffold or ECM into microplate wells, researchers encounter several difficulties. The reproducibility of results is decreased by this product inconsistency. decreasing the research's effectiveness in the process.
The market is severely constrained by a lack of standardisation and pricey 3D cell culture techniques. Furthermore, it is challenging to carry out the trials and expand at the expected CAGR given the growing ethical issues.
In-depth prospective opportunities in the market are anticipated as a result of 3-dimensional models' high applicability for research on respiratory illnesses and COVID-19. Organoids of the airway and the air-liquid interface have been used as experimental virology platforms to study the immune responses and infectivity of SARS-CoV-2 as well as tools for the creation and discovery of antiviral medications. Both scaffold-based and scaffold-free methods can be used to biofabricate accurate models that can be applied to the creation of brand-new COVID-19 therapies and vaccines. Other key factors driving market expansion include the launch of new products and the extensive application of 3D techniques in biological research. For instance, in December 2020, the Canadian biotechnology company eNUVIO Inc. unveiled the EB-Plate, a completely reusable microplate for 3D cell culture. This should increase the practicality of three-dimensional microplates, reduce the waste generated by single-use plastics, and advance the zero-waste movement in laboratories.
Common 2D analytical methods can be applied easily, much like the RAFT 3D cultures made by Lonza. Because they don't necessitate significant changes to the 2D culture techniques already in use, numerous laboratories all around the world have adopted these new technologies. Lonza has also developed 3D cell culture models to better in vitro hepatotoxicity testing, advance research on hepatic signalling networks, and study drug-induced liver injury.